SUMMARY Many different dosage schedules of antisecretory drugs for the treatment of duodenal ulcer are recommended. The relationship between degree of acid suppression and therapeutic efficacy has not been precisely defined for these drugs. We have examined the association between suppression of intragastric acidity and duodenal ulcer healing rates for a number of therapeutic regimens. For the H2 receptor antagonists alone, the most significant correlation with healing rates was with suppression of intragastric acidity at night (r=0-926; p=0-0001). When other classes of drug: high dose antacid, omeprazole and a synthetic prostaglandin (enprostil) were included in the analysis, the closest correlation was with suppression of total 24 hour intragastric acidity (r=0.91 1; p<00001). Stepwise linear regression analysis was used to investigate the relative contributions to healing of suppression of acidity during the day and night. Suppression of nocturnal acidity was found to be the single most 4 In selecting the optimal dose schedule of an antisecretory drug for duodenal ulcer, studies have usually been undertaken to examine the effect of the drug on 24 hour, and particularly on nocturnal intragastric acidity. This approach has now become widely accepted in the evaluation of any new antisecretory agent. The present study has attempted to appraise critically the effects of different dose schedules of available antisecretory agents on 24 hour and nocturnal intragastric acidity and nocturnal acid secretion in relation to duodenal ulcer healing to determine the optimal dose regimens from those studied to date.
Methods

PATIENTS
In order to explore the relationship between the suppression of gastric acid secretion and the healing of duodenal ulcer the principles of meta-analysis to correlation have been applied.`' This method permits the investigator to assess the significance of any relationship or trend from pooled data that might not be evident in any of the many smaller studies reported. Using this approach, we sought and reviewed all published studies of the clinical pharmacology of antisecretory drugs on 24 hour gastric secretion from the literature with a computer assisted Medline search. All those using aspiration techniques, and meeting the criteria described below, were included.4 ""' In such studies, measurements of intragastric pH taken hourly over a 24 hour period allow hydrogen ion activity, or acidity, to be derived. In these studies, special attention has traditionally been paid to acid secretion during the night. As subjects do not eat over this time, the entire gastric secretion can be collected by continuous aspiration. Hourly volume and titratable acidity are measured and acid output is calculated as the product of these two factors.
In order to pool data certain rules have been established by Goldman and Feinstein"" and have been used in all studies cited here. All had been undertaken in duodenal ulcer patients, all of whom were in remission, not taking treatment except under the conditions of study, and all studies measured pH (which was then converted to H' activity), with the exception of one which measured titrateable acidity. The at four weeks (r=0-68; n=11; p=0402). There was a highly significant correlation between suppression of nocturnal acidity and ulcer healing at four weeks (r=0.926; n=11; p=0-0001). By comparison, there was a poor correlation between ulcer healing and suppression of daytime acidity (r=0-02; n=11; p=0-96) or nocturnal acid output (r=0.17; n=7; p=0-71).
In order to test the validity of our formula for the calculation of daytime acidity, we applied it to three papers for which suppression of acid for the daytime period was clearly reported.'9326 For the 11 drug doses studied in these papers covering a wide range of acid suppression, not all were used in our metaanalysis, the deviation of our formula from the actual suppression varied from -2-2% to +0 8% (mean deviation 2.3%). Point 'a' on Figure 1 , which corresponds to cimetidine 200 mg qid, appears to be separate from the majority of the data points for the other dosage regimens. If this point were to be excluded from the analysis, however, there would still be a highly significant correlation (r=0-80; n=10; p=0 0054), and neither the slope nor the intercept of the line would change significantly. The insert in Figure 1 shows the relationship between suppression of 24 hour intragastric acidity and four week healing rates for the same 11 dose regimens of H2 receptor antagonists.
In view of the better correlation between healing and suppression of nocturnal rather than 24 hour acidity for the H2 receptor antagonists, stepwise linear regression analysis was performed to examine the relative importance of suppression of nocturnal and daytime acidity to overall healing rates. These results are presented in Table 2 . There is a significant (p=0.0004) association between suppression of acidity at night and ulcer healing. This is responsible for 86 1 % of observed variation in healing rates (R=0 861). When suppression of acidity by day is stepped into the analysis, there is no significant association with healing (p=0 67), and suppression of daytime acidity only contributes a further 033% to the observed variation in healing rates.
In Figure 2 , the relationship between suppression of 24 hour acidity and healing rates at four weeks is shown for all drugs studied. In addition to the 11 dose regimens of the H2 receptor antagonists, this also includes enprostil, a synthetic prostaglandin E2 analogue, in the dose of 35 p.g bd, antacid, 1000 mmol buffering capacity per day, and four doses of omeprazole (20, 30, 40 , and 60 mg per day). Between Figure 2 shows the relationship between suppression of nocturnal acidity and four week healing rates for all drugs studied. Although there is still a highly significant correlation (r=0.88; n=18; p<00005), this is not as strong as that seen with suppression of total 24 hour acidity, the converse of the situation observed above for the H2 receptor antagonists alone. When stepwise regression analysis techniques were applied to the data for all drugs (Table 3) , there was a significantly increased overall correlation by including suppression of daytime acidity in the analysis.
In Table 4 , the duodenal ulcer healing rates at two, four, six and eight weeks are shown for all regimens studied. The suppression of nocturnal acidity is also given for each regimen. Ulcer healing rates after eight weeks' treatment with large night time doses of H2 receptor antagonists are comparable to those seen with omeprazole at four weeks. Figure 3 shows the relationship between suppression of nocturnal acidity and duodenal ulcer healing rates after two, four, and eight weeks' treatment all classes of antisecretory drugs. It can be appreciated that the nature of the relationship differs at each of these timepoints, emphasising the important influence that duration of treatment has on any relationship between acid suppression and duodenal ulcer healing.
Discussion
This paper shows for the first time that there is a clear relationship between acid supression and the rate of duodenal ulcer healing. The methods which we have used to explore this relationship provide us with important information about those antisecretory drugs which are currently available for ulcer therapy and the optimal dosing of those doses so far investigated. The meta-analysis technique cannot be used, however, to determine precisely the optimal degree or duration of acid supression. Nevertheless it is clear that a similar analysis of the raw data from a large number of clinical pharmacological studies of acid suppression would probably provide information on a threshold for ulcer healing. A threshold secretion rate of 12 mmol/h for MAO to 15 mmol/h for PAO has been proposed by Baron4 from studies of stimulated acid secretion and this is widely used as a target in the treatment of patients with Zollinger-Ellison syndrome.
The validity of our methods of calculation of suppression of daytime acidity clearly was confirmed from applying this to those papers which measured daytime acidity'9'n The results show that we are within less than 2*5% of the observed.
Analysis of data for the H2 receptor antagonists alone demonstrates a highly significant relationship between four week healing rates for duodenal ulcer and reduction of nocturnal acidity. Furthermore, stepwise linear regression confirms that suppression of nocturnal acidity, with this class of drugs, is primarily responsible for the significant correlation between suppression of 24 hour acidity and four week healing rates. The importance of suppressing nocturnal acidity to achieve maximal healing rates for duodenal ulcer with H2 receptor antagonists is shown in Table 1 . With the exception of omeprazole, maximal healing rates of duodenal ulcer after four weeks treatment are achieved with nocturnal doses of H2 receptor antagonists.
The relationship between suppression of 24 hour and nocturnal acidity and ulcer healing at four weeks is linear in the range of suppression produced by H2 receptor antagonists (60 to 95%). The extrapolation (Table 1) gives healing rates at four weeks which is similar to cimetidine 800 mg nocte (30% smaller total daily dose).
The relative contribution of daytime versus night time suppression of acidity for omeprazole is more difficult to evaluate as this drug has a prolonged duration of action over the 24 hour period after once daily administration, whether taken in the morning or in the evening. 3 Although potent suppression of either 24 hour or nocturnal acidity leads to healing of duodenal ulcer, the data in Table 4 and Figure 3, 
